「with」の検索結果
108件：36～40件目を表示
-
nju is committed to obtaining marketing approval for the DED treatment SJP-0132 to provide patients with new options for alleviating the signs and symptoms of this disease. Mochida is dedicated to lev...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject...
https://www.senju.co.jp/english/about/production.html -
お知らせ | 千寿製薬株式会社
formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for BeelineMED”（PDF...
https://www.senju.co.jp/english/news/ -
し，適正使用に関する理解を促すため。 12 重要な不足情報 なし 引用文献 Touyz RM, Herrmann SMS, Herrmann J (2018) Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events. J Am Soc Hyperte...
https://www.senju.co.jp/system/files/rmp_document/2026-01/BEO_202511_01_RMP.pdf -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...
https://www.senju.co.jp/english/rd/society/